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Abstract
Background: Intussusception is the most common cause of bowel obstruction in infants with an incidence
ranging from 9–328 cases per 100,000 infants aged 0–11 months. Causes underlining this clinical manifestation are
still unknown. Possible relationship with a withdrawn tetravalent rotavirus vaccine was not confirmed by
post-licensure studies and actually no increased risk of intussusception was found between infants vaccinated with
both the recently licensed rotavirus vaccines. Aim of this study is to analyze the intussusception hospitalizations in
Sicily from 2003 to 2012 before the introduction of rotavirus universal vaccination and its possible relation with
rotavirus gastroenteritis trend.
Methods: Were collected data from hospital discharge records occurred from 1st January 2003 to 31st December
2012 in Sicily.
Intussusception cases were defined as all hospitalizations with an ICD-9-CM code of 560.0 on any discharge
diagnoses. As a proxy for the severity of cases were considered ICD-9-CM procedure codes accounting for surgical
or radiologic reduction.
Results: A total of 340 intussusception cases were hospitalized in Sicily from 2003 to 2012 in children aged
0–59 months. 46.8 % occurred in the age class 0–11 months.
Hospitalization rate for intussusception was 11.4 cases per 100,000 per year (32.6 cases per 100,000 among 0–11
months children; 7.3 cases per 100,000 among 12–59 months children), with a M:F sex ratio of 1.8.
During hospitalization only 25 % of intussusceptions had a spontaneous resolution, 56.5 % of cases required a
surgical intervention.
From 2003 to 2012 intussusception cases were equally distributed during the year without any seasonality, while
gastroenteritis hospitalizations due to rotavirus infection have a typically late winter and spring distribution.
Conclusions: In Sicily from 2003 to 2012 hospitalizations due to intestinal invagination were higher among children
aged 0–11 months with observed rates similar to other European countries. Regional baseline data analysis of
intussusception among 0–59 children is recognized as an evidence-based public health strategy by international
health authorities. Indeed, this strategy is necessary to compare any post-licensure age or sex-related change in
intussusception trend after universal rotavirus vaccination introduction.
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Background
Intussusception is the invagination of one segment of the
intestine within a more distal segment and it is the most
common cause of bowel obstruction in infants [1].
International epidemiological data suggest that its inci-
dence can vary greatly between different countries,
ranging from 9–328 cases per 100,000 infants aged 0–11
months per year, [1] raising a question as to whether
environmental factors and geographical variation may
influence the development of intussusception. Although
the causes underlining this clinical manifestation are still
unknown, intussusception increased its popularity in the
last two decades because of its potential association with
rotavirus vaccination [2].
The relationship was suggested for the first time in
1998 when a tetravalent rotavirus vaccine (RotaShield)
was withdrawn because of a significant excess risk of
intussusception among US infants during the weeks
following receipt of vaccine [3, 4]. Postlicensure sur-
veillance studies in the United States have not con-
firmed the previous finding and no increased risk of
intussusception was found between infants vaccinated
with both the recently licensed rotavirus vaccines
(RotaTeq, 2006; Rotarix, 2008) [5, 6]. More recently, in
Countries with implemented Rotavirus Universal Mass
Vaccination (UMV), some authors have described a
small increased risk of intussusceptions for infants re-
ceiving rotavirus vaccine, although it was evident that
the vaccines' benefits outweigh this risk [7–9].
To date, rotavirus vaccination represents the best
strategy for reducing severe rotavirus gastroenteritis
and, its associated costs due to mortality among young
children and healthcare utilization. Therefore, since
2009 the World Health Organization (WHO) has
recommended its introduction in all national im-
munization programs [10]. Despite of these recom-
mendations, the possible association between rotavirus
vaccination and increased risk of intussusception is
still an argument of concern for both public health
authorities, healthcare workers and general population,
often representing a major limit for rotavirus vaccin-
ation [2, 7].
Moreover, WHO [11] has recently recommended
that the baseline incidence of intussusception prior to
the introduction of rotavirus vaccines should be based
on recent local data, as temporal changes in the inci-
dence of intussusception, unrelated to vaccination,
have been reported in a number of regions [12–16].
According to this statement, the present paper has
aimed to evaluate incidence rates of intussusception
among infants hospitalized from 2003 to 2012 in Sicily,
the first administrative Italian region that introduced
rotavirus vaccination in its immunization program in
January 2013.
Methods
This study included data of hospitalizations occurred from
1st January 2003 to 31st December 2012 among subjects
aged 0 through 59 months and resident of Sicily, a region
accounting for about 5 million inhabitants with a newborn
cohort of about 50,000 children per year.
Hospital discharge records (HDR) were obtained
from the Sicily’s Health Regional Office, which rou-
tinely collects these data from all regional public and
private hospitals. Each HDR includes demographic
information (birthplace, residence, gender, and date of
birth), admission and discharge dates, discharge status
(categorized as “discharged/transferred” or “dead”), and
up to six discharge diagnoses (1 principal and 5 second-
ary diagnoses) coded according to International Classifi-
cation of Disease, Ninth Revision, Clinical Modification
(ICD-9-CM).
Cases of intussusception were defined as all hospitali-
zations with an ICD-9-CM diagnosis code of 560.0 in-
cluded as any of the discharge diagnoses. As a proxy for
the severity of cases were considered those ICD-9-CM
procedure codes which required a surgical (codes 46.80
to 46.82: intra-abdominal manipulation of the intestine,
various levels) or radiologic reduction (96.29: reduction
of intussusception of alimentary tract by fluoroscopy,
enema, ultrasonography, water, or air). Moreover, data
on rotavirus gastroenteritis (RVGE) observed in Sicily
(ICD-9-CM diagnosis code of 008.61 on any diagnosis
position), were also comparatively analyzed in the same
period, in order to evaluate a possible link between these
two pathologies [17]. Repeated cases of intussusception
and/or RVGE were excluded from the analysis due to an
anonymous code of identification.
The study was ethically approved by the Institutional
Review Board of the Azienda Ospedaliera Universitaria
Policlinico “Paolo Giaccone” of Palermo, Italy.
Statistical analysis
Quantitative variables were expressed as mean (standard
deviation = SD) when normally distributed, otherwise as
median (interquartile range = IQ range). Normality was
assessed using the Shapiro-Wilk test. Qualitative vari-
ables were summarized as frequency and percentage
with 95 % confidence intervals (CI). Hospitalization rates
(per 100,000) and CI 95 % for each investigated year
were calculated using the census population for children
aged five or less years [18]. Seasonality and trends in the
infants’ hospitalizations were analyzed after stratifying
by sex and age. To compare normally and not normally
distributed variables were used Student’s t-test and
Mann–Whitney test respectively. Chi-square and chi-
square for trends tests were used to compare categorical
variables. Statistical significance was set at p < 0.05
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(p values are two-tailed). All analyses were performed
using the STATA v11.2. software package.
Results
As showed in Table 1, a total of 340 intussusception cases
were hospitalized in Sicily from 2003 to 2012 in children
aged 0–59 months, accounting for an average of 34 (± SD
6.4) cases per year with a mean age of 18.9 months (± SD
15.6). About half (n = 159; 46.8 %) of hospitalization for
intussusceptions occurred in the age class 0–11 months.
Overall, during the study period the rate of hos-
pitalization for intussusception was 11.4 (± SD 2.4) cases
per 100,000 per year, greater in children aged from 0–
11 months (32.6 cases per 100,000; CI 95 %: 25.5-39.6)
than in children aged from 12 to 59 months (7.3 per
100,000; CI 95 %: 5.7-8.9) (p < 0.001).
The median length of hospitalization was 5 days (IQ
range 3–7) with a M:F sex ratio of 1.8.
During hospitalization 25.0 % of intussusceptions had
a spontaneous resolution, whereas, 63 cases (18.5 %)
were resolved with a barium or air enema treatment and
192 (56.5 %) required a surgical intervention (15 with
resection and 11 with unspecified surgery).
Length of hospital stay was longer in children with at
least one surgical treatment (with or without resection
or unspecified) than in children treated with air/barium
enema or spontaneous resolution (median days = 6 vs. 3;
p < 0.001). However, no statistically significant difference
was found in mean age among children with different
treatments (Table 1).
Figure 1 shows the trends of hospitalization for intus-
susception in Sicily that occurred, in the study period, in
children aged 0–11 months and 12–59 months.
Hospitalization rates among children aged 0–11 months
were characterized by a roughly wave pattern with a peak
in 2005 (48.2 per 100,000). On the other hand, children
aged 12–59 months reported a steadily increasing trend
by time with a nearly four-fold increased risk from 2003
to 2012 (Cox-Stuart trend test: p < 0.05).
As shown in Fig. 2, in Sicily from 2003 to 2012 intussus-
ception cases were equally distributed during all over the
year without any seasonality. On the contrary, RVGE
hospitalization were observed especially during late winter
and spring, with a peak in the month of April (1,344 cases)
and a high number of cases also in March (1,343) and May
(1,299) (Fig. 2).
Finally, analyzing the distribution of intussusception
hospitalization among children aged 0–59 months, was
observed a peak at 8 months (28 cases in the 10 years of
observation) (Fig. 3).
Discussion
Intussusception is a rare clinical condition that is
observed in almost all regions of the world, particularly
Table 1 Characteristics of children hospitalized for intussusceptions in Sicily (2003–2012)
N = 340
Gender, n (%)
Male 218 (64.1)
Female 122 (35.8)
Age, mean in months (IC95 %) 18.9 ± 15.6
Age classes in months, n (%)
0–11 months 159 (46.8)
12–59 months 181 (53.2)
Mean Hospitalization rate per 100,000 (IC95 %)
0–11 months 32.6 (25.5–39.6)
12–59 months 7.3 (5.7–8.9)
Sex ratio, M:F 1.8
Mean of intussusception hospitalizations per year (± SD) 34.0 ± 6.4
Hospitalization length, median in days (IQ range) 5 (3–7)
Treatment n (%) Hospitalization length, median in days (IQ range) Age, mean in months (± SD)
- Barium/air enema 63 (18.5) 4 (3–6) 20.6 (±14.8)
- Surgery 166 (48.8) 6 (4–8) 18.2 (±14.7)
- Surgery with resection 15 (4.4) 9 (8–10) 21.3 (±21.5)
- Spontaneous resolution 85 (25.0) 2 (1–4) 18.6 (±16.0)
- Unspecified surgery 11 (3.2) 7 (6–10) 21.8 (±20.7)
p-value <0.001 0.01
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among infants, regardless of rotavirus vaccination [1].
Considering that a large majority of intussusception cases
are diagnosed and treated in hospital, post-marketing
surveillance can be successfully carried out by hospital
discharge databases that allow a timely and inexpensive
collection of epidemiological information and include
standardized diagnosis code lists that enable secular trend
analysis of incident disease.
Results reported in the present study should be consid-
ered as the baseline incidence rate of hospitalization for in-
tussusception in Sicily in the anti-rotavirus pre-vaccination
era. Our results demonstrate among children aged 0–11 a
number of hospitalization lower (32.6 per 100,000) than
those estimated in other European countries with active
surveillance systems, such as Switzerland (38.0/100,000)
and Germany (60.4/100,000) [19, 20]. While underreporting
can occur in active surveillance systems which rely a lot on
clinical interest and involvement, underestimation is also
possible in passive surveillance systems due to coding/mis-
classification errors or by not including study subjects
treated in outpatient/short stay settings [19, 21, 22].
In line with other studies, our findings showed a male
predominance in the incidence of intussusception in Sicily
[15, 23]. Reasons for this finding may include changes in
feeding practices affecting the infant gut, maturation of
lymphoid tissue or a decline in maternal antibodies against
infectious agents possibly associated with intussusception
[15]. According to literature there was no possible explan-
ation of the intussusception male predominance observed
worldwide. Future study should enhance the possible ef-
fects caused by sexual hormones through specific analysis.
In the current study, length of hospital stay was not asso-
ciated with age but only with kind of intervention. Indeed,
children aged <12 months had a median hospitalization
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length similar to children aged ≥12 months. Conversely,
children aged ≥12 months were least likely to require sur-
gery, confirming data reported in previous studies [24, 25].
Frequently, in younger children the clinical expression
of intussusception is absent or indefinite, therefore
establishing the diagnosis based on the classic symptoms
alone may cause delay and, in turn, would result in a
higher rate of surgical intervention and intestinal resec-
tion [26].
Moreover, in Sicily, intussusception monthly trend
could not be related with observed RVGE rates and
peaks [17]. Indeed, our data confirmed the lack of sea-
sonality of intussusceptions in accordance with other
studies [19, 27]. The frequent association of intussus-
ception with hypertrophy of Peyer patches and mesen-
teric lymphadenopathy raises the possibility of one or
more infectious causes. In this sense, several pathogens,
such as adenovirus, human herpes virus HHV-6 and
HHV-7, Salmonella spp, E.coli, Campylobacter, and
Shigella spp, have been found in children with intussus-
ception [28]. Further studies may need to explore the
factors underlying the risk for intussusception and its
possible association with other infections. Finally, it
should be pointed out that, consistently with data re-
ported among other researchers [29], in our population
the peak of intussusceptions was found at 8 months
of age. Whilst, in Sicilian and other European settings
[17, 30] the peak of RVGE incidence was about 12 months
of age. These data seem to reinforce the lack of a causal
association between RVGE and intussusception.
Our data confirm that intussusception is an ex-
tremely rare condition in children under 5 months of
age and suggest that a correct administration of the
anti-RV vaccination within the first 5 months of age
could avoid an overlap of physiological and vaccine
related intussusception.
A limit of this study can be that from a previous study
found that more than 40 % of intussusception cases were
managed and discharged directly from emergency depart-
ment (ED) or short-stay settings and could be missed in
analyses using only inpatient discharge data [5].
If the proportion of intussusception cases admitted from
an ED setting is stable over time, inpatient data on intus-
susception should be a reasonable proxy for overall intus-
susception rates and should reflect trends over time.
Another limit of the study, due to restricted information
included in Sicilian HDRs, is the rather weak association
between RVGE and intussusception which cannot be sup-
ported with additional statistical analysis.
Conclusions
In general, considering that the use of regional baseline data
is of paramount importance when evaluating postlicensure
trends of intussusceptions for assessing any potential
vaccine-associated risk, the observed rates could represent
a significant evidence-based public health strategy, allowing
to monitor any age-related or sex-related change in intus-
susception risk following the introduction of the universal
rotavirus vaccination among infants in Sicily.
Finally, our data demonstrated the different seasonality of
intussusception and RVGE hospitalizations, hypothesizing a
lack of temporal association between these pathological
condition. Considering that available rotavirus vaccine was
mainly constituted by live attenuated virus, any temporal
association with vaccine or significant increase in intussus-
ception rate would be expected in post-licensure studies.
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